Multi-protocol exploratory treatment for metastatic castration-resistant prostate cancer with BRCA mutations: a case report and literature review

Most patients with metastatic hormone sensitive prostate cancer will progress to metastatic castration-resistant prostate cancer (mCRPC); Finding a highly effective, safe treatment with low recurrence rate has important clinical implications. Herein, we present a case of a 65-year-old man with castr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Dongsheng, Su, Wen, Zeng, Liang, Hu, Guoqian, Tang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206126/
https://www.ncbi.nlm.nih.gov/pubmed/37234981
http://dx.doi.org/10.3389/fonc.2023.1177941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206126/
https://www.ncbi.nlm.nih.gov/pubmed/37234981
http://dx.doi.org/10.3389/fonc.2023.1177941

Ejemplares similares